PharmaCyte Biotech's market cap is currently $5.83M. The company's EPS TTM is $0.76; its P/E ratio is -0.65; PharmaCyte Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
